<DOC>
	<DOCNO>NCT01040728</DOCNO>
	<brief_summary>The study intend characterize lung function profile BI1744 Chronic Obstructive Pulmonary Disease ( COPD ) patient patient perform pulmonary function test regular interval 24 hour end 6 week treatment period . Each patient receive four treatment .</brief_summary>
	<brief_title>A Randomized , Double-Blind , 4-way Crossover Study Evaluate Efficacy 24 Hour Spirometry Profiles Inhaled BI 1744 CL Inhaled Tiotropium Bromide Patients With Chronic Obstructive Pulmonary Disease</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Olodaterol</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<mesh_term>Bromides</mesh_term>
	<criteria>Inclusion criterion : Patients willing participate confirm diagnosis COPD 40 year age old 10 pack year smoke history able perform serial pulmonary function test able use Dry powder inhaler ( DPI ) Respimat device Exclusion criterion : Significant disease clinically relevant abnormal hematology , chemistry , urinalysis history asthma diagnosis thyrotoxicosis paroxysmal tachycardia relate beta agonist history MI within 1 year , cardiac arrhythmia , hospitalization heart failure within 1 year active tuberculosis , cystic fibrosis , clinically evident bronchiectasis significant alcohol drug abuse pulmonary resection take oral beta adrenergic take unstable oral steroid daytime oxygen enrol rehabilitation program enrol another study take investigational product pregnant nursing woman , woman child bear potential willing use two method birth control willing comply pulmonary medication washout</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>